Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
Journal website http://www.gastrores.org |
Original Article
Volume 11, Number 3, June 2018, pages 195-199
Possible Risk Factors for Candida Esophagitis in Immunocompetent Individuals
Figures
Tables
n (%) | |
---|---|
Comorbidities* | |
Asthma | 13 (16.3%) |
Hypertension | 11 (13.8%) |
Chronic obstructive pulmonary disease | 11 (13.8%) |
Hyperlipidemia | 7 (8.8%) |
Gallbladder stones | 6 (7.5%) |
Coronary artery disease | 4 (5.0%) |
Thyroid disorder (hypo- or hyperthyroidism) | 4 (5.0%) |
Atrial fibrillation | 3 (3.8%) |
Irritable bowel syndrome | 3 (3.8%) |
Liver cirrhosis | 2 (2.5%) |
Indication for endoscopy | |
Abdominal pain | 40 (50.0%) |
Evaluation of esophageal reflux | 13 (16.0%) |
Dysphagia | 9 (11.3%) |
Odynophagia | 5 (6.3%) |
Hematemesis | 4 (5.0%) |
Anemia | 4 (5.0%) |
Barrett’s disease (follow-up) | 2 (2.5%) |
Melena | 2 (2.5%) |
Screening for esophageal varices | 1 (1.3%) |
Endoscopic findings | |
White plaques and/or patches | 54 (67.5%) |
Esophagitis or esophageal friability, esophageal erythema | 20 (25.5%) |
Normal esophagus | 4 (5.0%) |
Esophageal ulcer | 1 (1.3%) |
Irregular z-line | 1 (1.3%) |
n (%) | |
---|---|
Proton pump inhibitor | 59 (73.8%) |
Corticosteroids (inhaled) | 15 (18.9%) |
No risk factors identified | 16 (20.0%) |
Gastroesophageal reflux | 50 (62.8%) |
Patients with previous endoscopies prior to CE diagnosis with findings of reflux esophagitis | 15 (18.8%) |
Patients who were started on a proton pump inhibitor therapy at the time of diagnosis of reflux esophagitis (15 patients with previous endoscopy) | 15 (100%) |